[LEGISLATIVE UPDATE] Cancer Drug Coverage Parity Act

[LEGISLATIVE UPDATE]  H.R. 1801: Cancer Drug Coverage Parity Act of 2013 – To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on … Continue reading


Each September, The Leukemia & Lymphoma Society (LLS) sponsors Blood Cancer Awareness Month to advocate for patients and help create awareness of blood cancers and the urgent need to fund research for lifesaving therapies. Over its 60-year history, LLS has invested nearly $1 billion to advance cancer therapies. Remarkable progress has been made, yet more … Continue reading

[GUEST BLOGGER] Author Joni Aldrich Speaks Up for Oral Parity in NC

  Oral chemotherapy parity should be simply that.  Chemotherapy is chemotherapy, whether it’s administered in the hospital/cancer center or at home–and thereby should be covered under major medical insurance instead of pharmacy benefits. Health insurance pharmaceutical coverage and the high cost of new oral chemotherapy drugs usually leave the cancer patient with large co-pays to … Continue reading